Dmitry Balyasny’s Sanofi SNY Stock Holding History

Dmitry Balyasny’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,600	Closed	-$271K	–	3432
2025 Q2	$271K	Buy	+5,600	New	+$286K	﹤0.01%	2505
2023 Q1	–	Sell	-260,000	Closed	-$12.6M	–	3114
2022 Q4	$12.6M	Sell	260,000 -880,000	-77%	-$38.6M	0.03%	641
2022 Q3	$43.3M	Buy	+1,140,000	New	+$50.8M	0.13%	184
2021 Q2	–	Sell	-50,000	Closed	-$4.21M	–	2319
2021 Q1	$4.21M	Buy	+50,000	New	+$2.4M	0.02%	756
2019 Q4	–	Sell	-100,000	Closed	-$4.63M	–	1466
2019 Q3	$4.63M	Buy	+100,000	New	+$4.31M	0.03%	562
2019 Q2	–	Sell	-270,000	Closed	-$12M	–	1709
2019 Q1	$12M	Buy	+270,000	New	+$11.6M	0.08%	348
2018 Q4	–	Sell	-400,000	Closed	-$17.7M	–	1733
2018 Q3	$17.7M	Buy	400,000 +175,000	+78%	+$7.48M	0.08%	336
2018 Q2	$9M	Sell	225,000 -300,000	-57%	-$11.8M	0.04%	518
2018 Q1	$21M	Buy	525,000 +399,400	+318%	+$16.6M	0.09%	314
2017 Q4	$5.4M	Buy	+125,600	New	+$5.79M	0.02%	833
2017 Q3	–	Sell	-1,537,500	Closed	-$73.7M	–	2082
2017 Q2	$73.7M	Buy	+1,537,500	New	+$73.5M	0.3%	70

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Dmitry Balyasny's SNY Position: Q2 2026 in Review

Dmitry Balyasny increased its Sanofi (SNY) stake by 189% in Q2 2026, buying an estimated $70.2M and bringing the position to 2,405,640 shares worth $103M. The position accounts for 0.13% of the portfolio, ranked #183.

Dmitry Balyasny first reported a position in SNY in Q4 2015 and has held it in 28 quarters since. The position peaked at $120M in Q2 2017. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Dmitry Balyasny held 2,405,640 shares of Sanofi worth $103M as of Q2 2026.
Dmitry Balyasny bought 1,571,860 Sanofi shares in Q2 2026, an estimated $70.2M.
Sanofi made up 0.13% of Dmitry Balyasny's portfolio in Q2 2026, its #183 holding.
Dmitry Balyasny first reported a position in Sanofi in Q4 2015 and has held it in 28 quarters since.
Dmitry Balyasny's Sanofi position peaked at $120M in Q2 2017.
714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.